<?xml version="1.0" encoding="UTF-8"?>
<ref id="B19">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dedrick</surname>
    <given-names>R. M.</given-names>
   </name>
   <name>
    <surname>Guerrero-Bustamante</surname>
    <given-names>C. A.</given-names>
   </name>
   <name>
    <surname>Garlena</surname>
    <given-names>R. A.</given-names>
   </name>
   <name>
    <surname>Russell</surname>
    <given-names>D. A.</given-names>
   </name>
   <name>
    <surname>Ford</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Harris</surname>
    <given-names>K.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2019</year>). 
  <article-title>Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant 
   <italic>Mycobacterium abscessus</italic>.
  </article-title>
  <source>
   <italic>Nat. Med.</italic>
  </source>
  <volume>25</volume>
  <fpage>730</fpage>â€“
  <lpage>733</lpage>. 
  <pub-id pub-id-type="doi">10.1038/s41591-019-0437-z</pub-id>
  <?supplied-pmid 31068712?>
  <pub-id pub-id-type="pmid">31068712</pub-id>
 </mixed-citation>
</ref>
